The Vanguard Group, Inc. has recently announced that it has increased stake in Omega Therapeutics Inc (NASDAQ:OMGA) by 0.10%. After grabbing 1.44 million shares, the institutional investor is now in possession of 1413.0 shares of the Healthcare Company. The new investment brought the stake of investor firm to 2.61% having worth around $3.29 million. Moreover, BlackRock Fund Advisors increased its share by 27327.0 to have a control over 1.34 million shares. And 683 Capital Management LLC raised its holdings to 33242.0 shares by acquiring 0.51 million shares or 0.92% of the stake.
Omega Therapeutics Inc (OMGA) concluded trading on 01/04/24 at a closing price of $5.32, with 88.13 million shares of worth about $468.87 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 12.13% during that period and on Thursday the price saw a gain of about 94.69%. Currently the company’s common shares owned by public are about 48.07M shares, out of which, 21.33M shares are available for trading.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
According to filings with the U.S. Securities and Exchange Commission (SEC), insiders took part in trade of the company’s stock for 7 times over the past 12 months. They bought 3,323,310 shares in 2 of the transactions. In 5 selling transactions, insiders dumped 45,000 shares.
Fidelity Growth Company Fund, Vanguard Total Stock Market ETF, and Fidelity Growth Company K6 Fund are the top 3 mutual funds which are holding stakes in Omega Therapeutics Inc Fidelity Growth Company Fund is currently holding 1.6 million shares of worth totaling $3.65 million. The company recently came buying 29200.0 shares which brought its stake up to 2.89% of the company’s outstanding shares. Fidelity Growth Company K6 Fund, after buying 0.76 million shares, have now control over 1.38% of the stake in the company. It holds 10200.0 shares of worth $1.74 million.
Omega Therapeutics Inc (NASDAQ: OMGA) started trading at $5.25, above $2.52 from concluding price of the previous day. However, the stock later moved at a day high price of 6.30, or with a gain of 94.69%. Stock saw a price change of 65.58% in past 5 days and over the past one month there was a price change of 144.93%. Year-to-date (YTD), OMGA shares are showing a performance of 76.58% which decreased to -7.73% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $1.30 but also hit the highest price of $11.98 during that period. The average intraday trading volume for Omega Therapeutics Inc shares is 247.70K. The stock is currently trading 105.69% above its 20-day simple moving average (SMA20), while that difference is up 151.86% for SMA50 and it goes to 13.25% higher than SMA200.
The Vanguard Group, Inc. acquired 1.44 million shares of Omega Therapeutics Inc having value of about $3.29 million. Data submitted at the U.S SEC by The Vanguard Group, Inc. revealed that the firm now holds 1413.0 shares in the company valued at close to $7517.16, or have control over 0.10% stake in the company. Omega Therapeutics Inc (NASDAQ: OMGA) currently have 48.07M outstanding shares and institutions hold larger chunk of about 32.93% of that. Holding of mutual funds in the company is about 21.20% while other institutional holders and individual stake holders have control over 54.60% and 11.75% of the stake respectively.
The stock has a current market capitalization of $293.07M and its 3Y-monthly beta is at 1.85. It has posted earnings per share of -$2.09 in the same period. It has Quick Ratio of 3.80 while making debt-to-equity ratio of 1.73. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for OMGA, volatility over the week remained 16.76% while standing at 12.22% over the month.
Analysts are in expectations that Omega Therapeutics Inc (OMGA) stock would likely to be making an EPS of -$0.45 in the current quarter, while forecast for next quarter EPS is -$0.41 and it is -$1.73 for next year. For the current quarter EPS, analysts have given the company a lowest target -$0.51 which is -$0.34 at the higher side of the target for the same. When we compare those targets with actual EPS, we find that company posted an EPS of -$0.64 in the same quarter a year ago. Stock’s fiscal year EPS is expected to rise by 11.45% while it is estimated to increase by 9.15% in next year.
Analysts at 6 brokerage firms have issued recommendations for the Omega Therapeutics Inc (OMGA)’s stock and average of those rates the stock at a “Strong Buy” and assign it a score of 1.00. Out of those 6 Wall Street analysts, 6 recommended a “Buy” rating, while 0 were in favor recommending the stock as a “Hold” and 0 analyst recommended the stock as “Sell”.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Jefferies on May 25, 2023 offering a Buy rating for the stock and assigned a target price range of between $18 and $15 to it.
